unit. As the isoprene units are small, their installation
allows for considerable flexibility. In contrast, we opted
to commence with tryptophan and piperidine fragments
and find suitable means for their stereocontrolled synthesis
and union.
The utility of cyclic tautomers of tryptophan7,8 in the
stereoselective synthesis of amino acid derivatives has been
studied.9,10 Chain-to-ring tautomerism gives structures
with a pronounced folded topology; in the wake of en-
olization events, trappings with electrophiles would occur
on the convex face of the molecule.11,12 We relied on this
propensity to stereoselectively join two halves of roughly
equal complexity. Subsequent chemo- and/or diastereose-
lective transformations were then used to complete a
synthesis of the citrinadin B core.
efficient carbonꢀcarbon bond formation and suppresses
byproduct formation with allyl bromide as an electrophile;
strict temperature control is required for desirable diaster-
eoselectivity favoring piperidine 6.16 Two-step oxidative
cleavage by initial dihydroxylation with substoichiometric
OsO4 and 1,4-diazabicyclo-[2.2.2]octane using K3Fe(CN)6
as a terminal oxidant followed by cleavage with substoi-
chiometric RuCl3 and excess NaIO4 furnishes acid 7. At
this point, electrophile 8 is formed by simple dehydrative
esterification of acid 7 with di-isopropylcarbodiimide and
pentafluorophenol.
Scheme 2. Preparation of Ester 8a
Scheme 1. Preparation of tert-Butyl Ester 4a
a DMAP = 4-(dimethylamino)pyridine.
Readily available acid 313 is esterified in good yield
though the intermediacy of an in situ generated mixed
carbonate, giving tert-butyl ester 4 (see Scheme 1).
The piperidine portion (see Scheme 2) is generated in
scalemic form starting with a classical resolution of (()-2-
methylpiperidine.14 Neutralization/carbamoylation then
gives N-tert-butoxycarbonyl-(R)-2-methylpiperidine (5).
This material is alkylated stereoselectively by modifying
conditions originally reported by Beak and co-workers.15
In particular, transmetalation to a Cu(I) salt promotes
a s-BuLi = sec-butyllithium; DABCO = 1,4-diazabicyclo[2.2.2]-
octane; DIC = di-isopropylcarbodiimide; TMEDA = N,N,N0,N0-tetra-
methylethylenediamine; THF = tetrahydrofuran.
The fragment union is accomplished by the following
sequence: (1) initial enolization of a slight excess of tert-
butyl ester 4 using lithium bis(trimethylsilyl)amide in cold
THF; (2) subsequent addition of hexamethylphosphora-
mide; (3) addition by cannula of a cold solution of penta-
fluorophenylester 8; and(4) cold-temperaturequenchwith
acetic acid (see Scheme 3).17 The delayed addition of
hexamethylphosphoramide minimizes deprotonation at
the benzylic site of the ester 4 (i.e., “lateral” deprotonation)
foundtooccur inoptimization studiesofthisreaction. This
mixed Claisen acylation generates β-keto ester 9 in 77%
isolated yield and with high diastereoselectivity. The great-
est erosion of diastereoselectivity arises if the reaction
mixture is not quenched cold with glacial acetic acid, which
leads to epimerization at C16 (citrinadin B numbering),
ostensibly by a β-eliminationꢀ1,4-addition mechanism.
Compound 9 is converted toβ-keto lactam 10by a three-
stage process wherein the following occurs: (1) the Boc
group is selectively removed using in situ-generated HCl;
(2) after evaporation to dryness of the methanolic mixture,
the resultant residue is taken up in anhydrous toluene and
treated with excess POCl3, and the mixture is heated at
(5) Kushida, N.; Watanabe, N.; Okuda, T.; Yokoyama, F.; Gyobu,
Y.; Yaguchi, T. J. Antiobiot. 2007, 60, 667.
(6) (a) Kushida, N.; Watanabe, N.; Yaguchi, T.; Yokoyama, F.;
Tsujiuchi, G.; Okuda, T. Novel Physiologically Active Substances
PF1270A, B and C. Eur. Pat. Appl. 1612273, 2004. (b) Kushida, N.;
Watanabe, N.; Yaguchi, T.; Yokoyama, F.; Tsujiuchi, G.; Okuda, T. U.S.
Patent 7,501,431, March 10, 2009.
(7) (a) Ohno, M.; Spande, T. F.; Witkop, B. J. Am. Chem. Soc. 1968,
90, 6521. (b) Ohno, M.; Spande, T. F.; Witkop, B. J. Am. Chem. Soc.
1970, 92, 343.
(8) Hino, T.; Taniguchi, M. J. Am. Chem. Soc. 1978, 100, 5564.
(9) Hino, T.; Nakagawa, M. Chemistry and Reactions of Cyclic
Tautomers of Tryptamines and Tryptophans. In The Alkaloids: Chem-
istry and Pharmacology; Brossi, A., Ed.; Academic Press, Inc.: San Diego,
1988; Vol. 34, pp 1ꢀ75.
(10) Crich, D.; Banerjee, A. Acc. Chem. Res. 1997, 40, 151.
(11) Crich, D.; Davies, J. W. Chem. Commun. 1989, 1418.
(12) Crich, D.; Bruncko, M. Tetrahedron Lett. 1992, 33, 6251.
(13) Prepared by saponification of the corresponding methyl ester.
See Supporting Information for experimental procedure. The starting
methyl ester has been reported (formerly available from Aldrich); see:
Chan, C.-O.; Crich, D.; Natarajan, N. Tetrahedron Lett. 1992, 33, 3405.
(14) Craig, J. C.; Pinder, A. R. J. Org. Chem. 1971, 36, 3648. A
modified procedure was employed, the details of which are provided in
the Supporting Information.
(16) Dieter, R. K.; Oba, G.; Chandupatla, K. R.; Topping, C. M.; Lu,
K.; Watson, R. T. J. Org. Chem. 2004, 69, 3076.
(17) For a similar strategic union via mixed Claisen acylation, see:
(15) (a) Beak, P.; Lee, W.-K. Tetrahedron Lett. 1989, 30, 1187. (b)
Beak, P.; Lee, W.-K. J. Org. Chem. 1993, 58, 1109.
Vaswani, R. G.; Chamberlin, A. R. J. Org. Chem. 2008, 73, 1661.
Org. Lett., Vol. 13, No. 19, 2011
5165